Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Summit Therapeutics Inc. (SMMT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Jan-31-19Jan-31-17Jan-31-16Jan-31-15Jan-31-14
   10-K10-K10-K/A10-K20-F20-F20-F20-F
Revenues:  
    UNITED STATES     56.1    
    Other     1.0    
Revenues  0.71.80.957.1 -29.70.20.3
            Revenue growth  -61.0%110.3%   -18627.4%-38.1% 
Cost of goods sold  -116.0-150.9-112.0-119.5 0.00.00.0
Gross profit  116.7152.7112.8176.6 -29.70.20.3
            Gross margin  16559.9%8441.6%13122.0%309.4% 100.0%100.0%100.0%
Selling, general and administrative   [+]26.723.619.217.0 4.40.00.1
Research and development  52.085.453.352.0 10.40.10.1
Other operating expenses  101.6129.992.796.9 -31.90.00.0
EBITDA   [+]-62.4-84.8-50.812.2    
            EBITDA margin  -8845.1%-4689.8%-5904.9%21.3% 42.8%36.6%34.5%
Depreciation  0.30.30.30.4    
EBITA  -62.7-85.2-51.111.8 -12.70.10.1
            EBITA margin  -8894.6%-4708.1%-5940.0%20.6% 42.8%36.6%34.5%
Amortization of intangibles  0.91.01.31.1    
EBIT   [+]-63.6-86.2-52.310.7 -12.70.10.1
            EBIT margin  -9024.3%-4764.3%-6085.3%18.7% 42.8%36.6%34.5%
Non-recurring items   [+]8.5 0.95.3    
Interest expense, net   [+]-1.5 0.00.0    
Other income (expense), net  -3.8-2.20.54.3 0.10.00.0
Pre-tax income  -78.8-88.6-52.99.1 -12.70.10.1
Income taxes  0.00.0-0.2-1.8 0.00.00.0
            Tax rate  0.0%0.0%0.4%  0.0%0.0%0.0%
Net income  -78.8-88.6-52.710.9 0.00.00.0
            Net margin  -11174.8%-4897.8%-6127.6%19.0% 0.0%0.0%0.0%
   
Basic EPS   [+]($0.41)($0.67)($0.76)$0.63    
Diluted EPS   [+]($0.41)($0.67)($0.76)$0.63    
   
Shares outstanding (basic)   [+]193.3131.769.517.1    
Shares outstanding (diluted)   [+]193.3131.769.517.2    
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy